Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Exanthema | 2 | 2022 | 30 | 1.580 |
Why?
|
| Skin Neoplasms | 3 | 2022 | 375 | 1.140 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2022 | 11 | 0.830 |
Why?
|
| Nevus, Pigmented | 1 | 2022 | 30 | 0.820 |
Why?
|
| Melanoma | 2 | 2022 | 335 | 0.780 |
Why?
|
| Telangiectasis | 1 | 2021 | 6 | 0.760 |
Why?
|
| Groin | 1 | 2020 | 11 | 0.720 |
Why?
|
| Skin Diseases, Vascular | 1 | 2019 | 3 | 0.700 |
Why?
|
| Angiomatosis | 1 | 2019 | 5 | 0.700 |
Why?
|
| Calciphylaxis | 1 | 2019 | 7 | 0.690 |
Why?
|
| Dermis | 1 | 2019 | 29 | 0.680 |
Why?
|
| Molluscum Contagiosum | 1 | 2019 | 3 | 0.660 |
Why?
|
| Pathology | 1 | 2017 | 17 | 0.580 |
Why?
|
| Certification | 1 | 2017 | 66 | 0.550 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2015 | 18 | 0.530 |
Why?
|
| Connective Tissue Diseases | 1 | 2015 | 18 | 0.520 |
Why?
|
| Lipoma | 1 | 2015 | 24 | 0.520 |
Why?
|
| Lymphoma, B-Cell | 1 | 2016 | 40 | 0.520 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2015 | 28 | 0.510 |
Why?
|
| Hemangioma | 1 | 2015 | 51 | 0.510 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2015 | 8 | 0.500 |
Why?
|
| Diagnosis, Differential | 6 | 2022 | 1140 | 0.470 |
Why?
|
| Tongue Diseases | 1 | 2012 | 14 | 0.430 |
Why?
|
| Angioedema | 1 | 2012 | 41 | 0.420 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 481 | 0.410 |
Why?
|
| Clinical Competence | 1 | 2017 | 657 | 0.400 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 202 | 0.390 |
Why?
|
| Heart Failure | 1 | 2019 | 1180 | 0.370 |
Why?
|
| Humans | 20 | 2022 | 68618 | 0.340 |
Why?
|
| Immunocompromised Host | 1 | 2022 | 55 | 0.210 |
Why?
|
| Hair Follicle | 1 | 2021 | 37 | 0.190 |
Why?
|
| Nevus, Intradermal | 1 | 2020 | 1 | 0.190 |
Why?
|
| Pilot Projects | 2 | 2022 | 1342 | 0.190 |
Why?
|
| Neuroectodermal Tumors | 1 | 2020 | 1 | 0.190 |
Why?
|
| Alopecia | 1 | 2021 | 45 | 0.190 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2020 | 5 | 0.190 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2020 | 24 | 0.190 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 159 | 0.180 |
Why?
|
| Skin Abnormalities | 1 | 2020 | 11 | 0.180 |
Why?
|
| Antigens, Neoplasm | 1 | 2020 | 132 | 0.180 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2020 | 144 | 0.170 |
Why?
|
| Urticaria Pigmentosa | 1 | 2019 | 5 | 0.170 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2020 | 194 | 0.170 |
Why?
|
| Thigh | 1 | 2019 | 27 | 0.160 |
Why?
|
| Male | 7 | 2019 | 37321 | 0.160 |
Why?
|
| Calcinosis | 1 | 2020 | 241 | 0.160 |
Why?
|
| Erythrocytes | 1 | 2018 | 137 | 0.160 |
Why?
|
| Anus Diseases | 1 | 2018 | 5 | 0.160 |
Why?
|
| Dermatitis | 1 | 2018 | 28 | 0.150 |
Why?
|
| Psoriasis | 1 | 2018 | 46 | 0.150 |
Why?
|
| Crohn Disease | 1 | 2018 | 38 | 0.150 |
Why?
|
| Middle Aged | 4 | 2019 | 21147 | 0.150 |
Why?
|
| Immunohistochemistry | 2 | 2020 | 1174 | 0.150 |
Why?
|
| Female | 6 | 2020 | 38074 | 0.140 |
Why?
|
| Specialty Boards | 1 | 2017 | 24 | 0.140 |
Why?
|
| Biopsy | 2 | 2019 | 540 | 0.140 |
Why?
|
| Spinal Nerve Roots | 1 | 2015 | 9 | 0.130 |
Why?
|
| Granular Cell Tumor | 1 | 2015 | 9 | 0.130 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2015 | 24 | 0.130 |
Why?
|
| Neck | 1 | 2015 | 62 | 0.130 |
Why?
|
| Educational Measurement | 1 | 2017 | 254 | 0.130 |
Why?
|
| Polyps | 1 | 2015 | 12 | 0.120 |
Why?
|
| Skull Neoplasms | 1 | 2015 | 23 | 0.120 |
Why?
|
| Aged | 2 | 2019 | 14862 | 0.100 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 508 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2017 | 596 | 0.100 |
Why?
|
| Adolescent | 2 | 2020 | 8912 | 0.090 |
Why?
|
| Retrospective Studies | 1 | 2019 | 7277 | 0.070 |
Why?
|
| United States | 1 | 2017 | 7367 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2020 | 2455 | 0.060 |
Why?
|
| Ribonuclease III | 1 | 2020 | 16 | 0.050 |
Why?
|
| Gene Rearrangement | 1 | 2020 | 19 | 0.050 |
Why?
|
| Melanocytes | 1 | 2020 | 23 | 0.050 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2020 | 20 | 0.050 |
Why?
|
| BRCA1 Protein | 1 | 2020 | 30 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 43 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2020 | 111 | 0.050 |
Why?
|
| Sarcoma, Ewing | 1 | 2020 | 26 | 0.050 |
Why?
|
| Heel | 1 | 2020 | 5 | 0.050 |
Why?
|
| Observer Variation | 1 | 2020 | 330 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 306 | 0.040 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2019 | 91 | 0.040 |
Why?
|
| Condylomata Acuminata | 1 | 2018 | 12 | 0.040 |
Why?
|
| Colonoscopy | 1 | 2018 | 156 | 0.040 |
Why?
|
| Inflammation | 1 | 2021 | 1030 | 0.030 |
Why?
|
| Cervical Vertebrae | 1 | 2015 | 86 | 0.030 |
Why?
|
| Infant | 1 | 2020 | 2891 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 5717 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 21403 | 0.010 |
Why?
|